Guidelines for the Diagnosis, Treatment and Prevention of Leprosy

Guidelines Development Group; External Review Group; WHO Steering Group

Guidelines for the Diagnosis, Treatment and Prevention of Leprosy

Guidelines Development Group, External Review Group, WHO Steering Group

Applied Health Sciences

Oregon Health and Science University

Research output: Book/Report › Commissioned Report

45 Downloads (Pure)

Original language	English
Place of Publication	New Delhi
Publisher	World Health Organization
Commissioning body	World Health Organization
Number of pages	106
ISBN (Print)	9789290226383
Publication status	Published - 20 Aug 2018

Bibliographical note

The development of these guidelines was coordinated by Laura Gillini, Medical Officer, Global Leprosy Programme (GLP) and supervised by Erwin Cooreman, GLP Team Leader.
The GLP would like to thank members of the Guidelines Development Group (GDG), members of the External Review Group (ERG), and World Health Organization (WHO) staff who contributed to the development of these guidelines as part of the Steering Group or as peer reviewers. The GLP appreciates the input provided by the national leprosy programmes of the following countries: Colombia, the Democratic Republic of the Congo, India, Morocco and the Philippines. The GLP is particularly grateful to the persons affected by leprosy who participated in focus group discussions in Colombia, Ghana, India and Nepal on diagnosis, treatment and contact screening.
The guidelines for the diagnosis, treatment and prevention of leprosy were developed with full funding support from The Nippon Foundation.

Access to Document

WHO Leprosy Guidelines -2018 August 20th - Guidelines for the diagnosis treatment and prevention of leprosy
© World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Final published version, 3.1 MBLicence: CC BY-NC-SA

Cite this

@book{e0aec1b446064064b2f58ae6ac4226c7,

title = "Guidelines for the Diagnosis, Treatment and Prevention of Leprosy",

author = "Roger Chou and Amudha Poobalan and {Guidelines Development Group} and {External Review Group} and {WHO Steering Group}",

note = "The development of these guidelines was coordinated by Laura Gillini, Medical Officer, Global Leprosy Programme (GLP) and supervised by Erwin Cooreman, GLP Team Leader. The GLP would like to thank members of the Guidelines Development Group (GDG), members of the External Review Group (ERG), and World Health Organization (WHO) staff who contributed to the development of these guidelines as part of the Steering Group or as peer reviewers. The GLP appreciates the input provided by the national leprosy programmes of the following countries: Colombia, the Democratic Republic of the Congo, India, Morocco and the Philippines. The GLP is particularly grateful to the persons affected by leprosy who participated in focus group discussions in Colombia, Ghana, India and Nepal on diagnosis, treatment and contact screening. The guidelines for the diagnosis, treatment and prevention of leprosy were developed with full funding support from The Nippon Foundation.",

year = "2018",

month = aug,

day = "20",

language = "English",

isbn = "9789290226383",

publisher = "World Health Organization ",

}

TY - BOOK

T1 - Guidelines for the Diagnosis, Treatment and Prevention of Leprosy

AU - Guidelines Development Group

AU - External Review Group

AU - WHO Steering Group

A2 - Chou, Roger

A2 - Poobalan, Amudha

N1 - The development of these guidelines was coordinated by Laura Gillini, Medical Officer, Global Leprosy Programme (GLP) and supervised by Erwin Cooreman, GLP Team Leader. The GLP would like to thank members of the Guidelines Development Group (GDG), members of the External Review Group (ERG), and World Health Organization (WHO) staff who contributed to the development of these guidelines as part of the Steering Group or as peer reviewers. The GLP appreciates the input provided by the national leprosy programmes of the following countries: Colombia, the Democratic Republic of the Congo, India, Morocco and the Philippines. The GLP is particularly grateful to the persons affected by leprosy who participated in focus group discussions in Colombia, Ghana, India and Nepal on diagnosis, treatment and contact screening. The guidelines for the diagnosis, treatment and prevention of leprosy were developed with full funding support from The Nippon Foundation.

PY - 2018/8/20

Y1 - 2018/8/20

M3 - Commissioned Report

SN - 9789290226383

BT - Guidelines for the Diagnosis, Treatment and Prevention of Leprosy

PB - World Health Organization

CY - New Delhi

ER -